BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18222727)

  • 1. Targeting Na+/H+ exchanger regulation for cardiac protection: a RSKy approach?
    Avkiran M; Cook AR; Cuello F
    Curr Opin Pharmacol; 2008 Apr; 8(2):133-40. PubMed ID: 18222727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Na+/H+ exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach.
    Kevelaitis E; Qureshi AA; Mouas C; Marotte F; Kevelaitiene S; Avkiran M; Menasché P
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):111-6. PubMed ID: 15621481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHE-1: still a viable therapeutic target.
    Karmazyn M
    J Mol Cell Cardiol; 2013 Aug; 61():77-82. PubMed ID: 23429008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of NHE-1 in myocardial hypertrophy and remodelling.
    Karmazyn M; Kilić A; Javadov S
    J Mol Cell Cardiol; 2008 Apr; 44(4):647-53. PubMed ID: 18329039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiac Na-H exchanger: a key downstream mediator for the cellular hypertrophic effects of paracrine, autocrine and hormonal factors.
    Fliegel L; Karmazyn M
    Biochem Cell Biol; 2004 Dec; 82(6):626-35. PubMed ID: 15674430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Substituted (benzo[b]thiophene-2-carbonyl)guanidines as novel Na+/H+ exchanger isoform-1 (NHE-1) inhibitors.
    Lee S; Lee H; Yi KY; Lee BH; Yoo SE; Lee K; Cho NS
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2998-3001. PubMed ID: 15914000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects.
    Avkiran M; Marber MS
    J Am Coll Cardiol; 2002 Mar; 39(5):747-53. PubMed ID: 11869836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NHE-1 and NBC during pseudo-ischemia/reperfusion in rabbit ventricular myocytes.
    van Borren MM; Baartscheer A; Wilders R; Ravesloot JH
    J Mol Cell Cardiol; 2004 Aug; 37(2):567-77. PubMed ID: 15276026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical resistance to myocardial ischemia and age-related cardiomyopathy in NHE1 transgenic mice: a role for ER stress?
    Cook AR; Bardswell SC; Pretheshan S; Dighe K; Kanaganayagam GS; Jabr RI; Merkle S; Marber MS; Engelhardt S; Avkiran M
    J Mol Cell Cardiol; 2009 Feb; 46(2):225-33. PubMed ID: 19027022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Na+/H+ exchanger isoform 1.
    Fliegel L
    Int J Biochem Cell Biol; 2005 Jan; 37(1):33-7. PubMed ID: 15381146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NHE-1 inhibition: from protection during acute ischaemia/reperfusion to prevention/reversal of myocardial remodelling.
    Linz WJ; Busch AE
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):239-46. PubMed ID: 14504689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Na+/H+ exchange inhibitor cariporide is washed out of the myocardium by crystalloid cardioplegia.
    Bechtel JF; Eichler W; Toerber K; Weidtmann B; Hernandez M; Klotz KF; Sievers HH; Bartels C
    Thorac Cardiovasc Surg; 2006 Aug; 54(5):317-23. PubMed ID: 16902879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protection at a crossroads: the need for translation into clinical therapy.
    Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
    Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
    Wang S; Peng Q; Zhang J; Liu L
    Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-hydrogen exchangers (NHE) in human cardiovascular diseases: interfering strategies and their therapeutic applications.
    Madonna R; De Caterina R
    Vascul Pharmacol; 2013; 59(5-6):127-30. PubMed ID: 24140414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
    Siddique I; Hasan F; Khan I
    Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel ligustrazine derivatives as NA+/H+ exchange inhibitors.
    Ren M; Dong J; Xu Y; Wen N; Gong G
    Chem Biodivers; 2010 Nov; 7(11):2727-36. PubMed ID: 21072772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure.
    Karmazyn M
    Expert Opin Investig Drugs; 2001 May; 10(5):835-43. PubMed ID: 11322861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of sodium-hydrogen exchange in cardiac hypertrophy and heart failure: a novel and promising therapeutic target.
    Karmazyn M
    Basic Res Cardiol; 2001 Jul; 96(4):325-8. PubMed ID: 11518188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.